Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers-Reference-Cited by-同舟云学术

Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers

Published:2017-02 Issue: Volume:247 Page:73-85
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

England Richard M.,Hare Jennifer I.,Barnes Jennifer,Wilson Joanne,Smith Aaron,Strittmatter Nicole,Kemmitt Paul D.,Waring Michael J.,Barry Simon T.,Alexander Cameron,Ashford Marianne B.

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework;Cook;Nat. Rev. Drug Discov.,2014

2. Drugging topoisomerases: lessons and challenges;Pommier;ACS Chem. Biol.,2013

3. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11;Kawato;Cancer Res.,1991

4. Cancer nanomedicine: progress, challenges and opportunities;Shi;Nat. Rev. Cancer,2017

5. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity;Maeda;Adv. Drug Deliv. Rev.,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered PLGA Core–Lipid Shell Hybrid Nanocarriers Improve the Efficacy and Safety of Irinotecan to Combat Colon Cancer;ACS Biomaterials Science & Engineering;2024-09-13

2. An overview on recent approaches for colonic drug delivery systems;Pharmaceutical Development and Technology;2024-06-20

3. Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology;Pharmaceuticals;2024-05-24

4. Enhancement of the efficacy of synthetic and natural anticancer agents through nanocarrier for colon cancer treatment;European Journal of Medicinal Chemistry Reports;2024-04

5. In Vivo Applications of Dendrimers: A Step toward the Future of Nanoparticle-Mediated Therapeutics;Pharmaceutics;2024-03-22